DISULFIRAM
SMILES | CCN(CC)C(=S)SSC(=S)N(CC)CC |
InChIKey | AUZONCFQVSMFAP-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 4 |
Hydrogen bond donors | 0 |
Rotatable bonds | 4 |
Molecular weight (Da) | 296.1 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | No |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT1B | 5HT1B | Rat | 5-Hydroxytryptamine | A | pKi | 5.67 | 5.67 | 5.67 | ChEMBL |
CCR4 | CCR4 | Human | Chemokine | A | pKi | 5.36 | 5.36 | 5.36 | ChEMBL |
CXCR2 | CXCR2 | Human | Chemokine | A | pKi | 5.38 | 5.38 | 5.38 | ChEMBL |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 5.83 | 5.83 | 5.83 | ChEMBL |
CCR2 | CCR2 | Human | Chemokine | A | pKi | 6.02 | 6.02 | 6.02 | ChEMBL |
CCR5 | CCR5 | Human | Chemokine | A | pKi | 4.74 | 4.74 | 4.74 | ChEMBL |
D4 | DRD4 | Human | Dopamine | A | pKi | 5.96 | 5.96 | 5.96 | ChEMBL |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 5.74 | 5.74 | 5.74 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pKi | 5.97 | 5.97 | 5.97 | ChEMBL |
5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pKi | 5.13 | 5.13 | 5.13 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 4.66 | 4.66 | 4.66 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pKi | 6.43 | 6.43 | 6.43 | ChEMBL |
A3 | AA3R | Human | Adenosine | A | pKi | 6.7 | 6.7 | 6.7 | ChEMBL |
κ | OPRK | Human | Opioid | A | pKi | 5.61 | 5.61 | 5.61 | ChEMBL |
μ | OPRM | Human | Opioid | A | pKi | 5.85 | 5.85 | 5.85 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 5.12 | 5.12 | 5.12 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 8.33 | 8.33 | 8.33 | Drug Central |
5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pKi | 8.29 | 8.29 | 8.29 | Drug Central |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.24 | 8.24 | 8.24 | Drug Central |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 8.23 | 8.23 | 8.23 | Drug Central |
D1 | DRD1 | Human | Dopamine | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.29 | 8.29 | 8.29 | Drug Central |
D3 | DRD3 | Human | Dopamine | A | pKi | 8.19 | 8.19 | 8.19 | Drug Central |
D4 | DRD4 | Human | Dopamine | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
κ | OPRK | Human | Opioid | A | pKi | 8.25 | 8.25 | 8.25 | Drug Central |
μ | OPRM | Human | Opioid | A | pKi | 8.23 | 8.23 | 8.23 | Drug Central |
CCR2 | CCR2 | Human | Chemokine | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
CCR5 | CCR5 | Human | Chemokine | A | pKi | 8.32 | 8.32 | 8.32 | Drug Central |
CXCR2 | CXCR2 | Human | Chemokine | A | pKi | 8.27 | 8.27 | 8.27 | Drug Central |
A3 | AA3R | Human | Adenosine | A | pKi | 8.17 | 8.17 | 8.17 | Drug Central |
5-HT1B | 5HT1B | Rat | 5-Hydroxytryptamine | A | pKi | 8.25 | 8.25 | 8.25 | Drug Central |
CCR4 | CCR4 | Human | Chemokine | A | pKi | 8.27 | 8.27 | 8.27 | Drug Central |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT1B | 5HT1B | Rat | 5-Hydroxytryptamine | A | pIC50 | 5.33 | 5.33 | 5.33 | ChEMBL |
CCR4 | CCR4 | Human | Chemokine | A | pIC50 | 5.08 | 5.08 | 5.08 | ChEMBL |
M1 | ACM1 | Rat | Acetylcholine (muscarinic) | A | Potency | 4.9 | 4.9 | 4.9 | ChEMBL |
CXCR2 | CXCR2 | Human | Chemokine | A | pIC50 | 5.22 | 5.22 | 5.22 | ChEMBL |
α2B | ADA2B | Human | Adrenoceptors | A | pIC50 | 5.49 | 5.49 | 5.49 | ChEMBL |
AT1 | AGTR1 | Human | Angiotensin | A | pIC50 | 5.18 | 5.18 | 5.18 | ChEMBL |
CCR2 | CCR2 | Human | Chemokine | A | pIC50 | 5.61 | 5.61 | 5.61 | ChEMBL |
CCR5 | CCR5 | Human | Chemokine | A | pIC50 | 4.63 | 4.63 | 4.63 | ChEMBL |
D4 | DRD4 | Human | Dopamine | A | pIC50 | 5.5 | 5.5 | 5.5 | ChEMBL |
α2A | ADA2A | Human | Adrenoceptors | A | pIC50 | 5.31 | 5.31 | 5.31 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pIC50 | 5.67 | 5.67 | 5.67 | ChEMBL |
5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pIC50 | 4.8 | 4.8 | 4.8 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pIC50 | 4.46 | 4.46 | 4.46 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pIC50 | 5.96 | 5.96 | 5.96 | ChEMBL |
A3 | AA3R | Human | Adenosine | A | pIC50 | 6.45 | 6.45 | 6.45 | ChEMBL |
κ | OPRK | Human | Opioid | A | pIC50 | 5.21 | 5.21 | 5.21 | ChEMBL |
μ | OPRM | Human | Opioid | A | pIC50 | 5.46 | 5.46 | 5.46 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pIC50 | 4.64 | 4.64 | 4.64 | ChEMBL |
TSH | TSHR | Human | Glycoprotein hormone | A | Potency | 4.5 | 4.5 | 4.5 | ChEMBL |
NPS | NPSR1 | Human | Neuropeptide S | A | Potency | 4.5 | 4.8 | 5.1 | ChEMBL |